期刊文献+

NF-κB对PPARδ基因的转录调控 被引量:3

NF-κB Regulates PPARδ Expression at the Transcriptional Level
在线阅读 下载PDF
导出
摘要 过氧化物酶体增殖因子活化受体δ基因(PPARδ)与结直肠癌相关,但其转录调控机制尚不清楚.本研究构建了PPARδ基因的启动子荧光素酶报告基因载体,用删除法定位了启动子活性区域,并通过核酸重叠法和电泳迁移率变更实验,将该区域缩小到30bp,预测该区域可能起作用的转录因子结合位点;通过启动子定点突变分析和核酸诱骗实验,发现真正起作用的是-156^-127区域内NF-κB的结合位点.电泳迁移率变更法和超迁移分析实验,证实NF-κB能够与该区域结合,并且在抑制NF-κB的DNA结合活性后,PPARδmRNA的表达明显降低.这些实验表明,在Lovo细胞中,转录因子NF-κB参与了PPARδ的表达调控. Peroxisome proliferator-activated receptors gene(PPARδ) has been validated to be correlated with colorectal carcinogenesis; however, the mechanism of transcriptional regulation remains unclear. Our experiment is to address this issue. In this study, the PPARδpromoter was constructed into luciferase report gene vector. A functional region in the promoter was identified by deletion analysis and then the length was restricted to 30 bp by overlapping methods and EMSA. Possible transcriptional factor binding sites residing in the region were predicted, and site-directed mutagenesis analysis and decoy analysis demonstrated that the functional transcriptional factor binding site was the NF-κB binding site residing in a region extending from - 156 to - 127 in the PPARδ promoter. EMSA and supershift assay confirmed that NF-κB could bind to this region, and PPARδ mRNA expression decreased significantly after the DNA binding activity of NF-κB was inhibited. In conclusion, NF-κB is the transcriptional factor that contributes to the PPARδexpression in Lovo cells.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2008年第10期931-937,共7页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金资助项目(No.30471914)~~
关键词 过氧化物酶体增殖因子活化受体δ NF-ΚB 结直肠癌 转录调控 peroxisome proliferator-activated receptorδ (PPARδ)PPARδ NF-κB colorectal carcinoma transcriptional regulation
作者简介 联系人Tel:010—82805138,E-mail:zbmao@bjmu.edu.cn
  • 相关文献

参考文献19

  • 1Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity [ J ]. Diabetes, 2004, 53 (Suppl 1): S43-50
  • 2Moller D E, Berger J P. Role of PPARs in the regulation of obesityrelated insulin sensitivity and inflammation[ J ]. Int J Obesity Relat Metab Disord, 2003, 27(Suppl 13):S17-21
  • 3Wahli W. Peroxisome proliferator-activated receptors (PPARs) : from metabolic control to epidermal wound healing[J].Swiss Med Wkly, 2002, 132(7-8) :83-91
  • 4Burdick A D, Kim D J, Peraza M A, et al. The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation[J]. Cell Signal, 2006, 15(1) :9-20
  • 5Wang D, Mann J R, DuBois R N. WNT and cyclooxygenase-2 crosstalk accelerates adenoma growth [ J ]. Cell Cycle, 2004, 3 (12) : 1512-1515
  • 6Lira H, Dey S K. PPAR delta functions as a prostaeyclin receptor in blastoeyst implantation[J].Trends Endoerinol Metab, 2000, 11 (4) : 137-142
  • 7钟芸诗,姚礼庆,孙益红.过氧化物酶体增殖因子活化受体δ(PPARδ)在大肠腺瘤、癌中的表达及其意义[J].中国临床医学,2004,11(6):1040-1042. 被引量:2
  • 8Takayama O, Yamamoto H, Damdinsuren B, et al. Expression of PPARdeha in multistage carcinogenesis of the coloreetum: implications of malignant cancer morphology [J]. Br J Cancer, 2006, 95(7) :889-895
  • 9Andrews N C, Failer D V, A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells[J]. Nucl Acid Res, 1991, 19(9) :2499
  • 10HeT C, Chan T A, Vogelstein B, et al. PPARD is an A PC-regulated target of nonsteroidal anti-inflammatory drugs[J]. Cell, 1999, 99 (8): 335-345

二级参考文献8

  • 1He TC, Chan TA, Vogelstein B, et al. PPAR δ is an APCRegulated Target of Nonsteroidal Anti - Inflammatory Drugs.Cell, 1999, 44(3): 336-345.
  • 2Ricchi P, Zarrilli R, Di Palma A, et al. Minireview: Nonsteroidal anti- inflammatory drugs in colorectal cancer: from prevention to therapy. Br J Cancer, 2003, 88: 803-807.
  • 3Brockman JA, Gupta RA, DuBois RN. Activation of PPAR β elads to inhibition of anchorage - independent growth of human colorectal cancer cells. Gastroenterology, 1998, 115(5): 1049-1055.
  • 4Debril MB, Auwerx J. The pleiotropic function of peroxisome proliferators activated receptor β. M Mol Med, 2001, 79: 30-47.
  • 5Barak Y, Liao D, He W, et al. Effects of peroxisome proliferatoractivated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci USA, 2002, 99(1): 303-308.
  • 6Rajnish AG, Jeffrey AB, Pasha S, et al. target genes of peroxisome proliferator-activated receptor δ in colorectal cancer cells J Biol chem, 2001, 276:29681-29687
  • 7Thun MJ. Aspirin and gastrointestinal cancer. Adv Exp Med Biol, 1997, 400A: 395-402.
  • 8Giardiello FM, Yang VW, Hylind LM, et al. Primary chemoprevention of familial adenomatous polyposis with sulindac. NEJM, 2002, 346: 1054-1059.

共引文献1

同被引文献48

  • 1Yu-JunLi Zhi-MinWei Yun-XiaoMeng Xiang-RuiJi.β-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: Relationships with carcinogenesis and metastasis[J].World Journal of Gastroenterology,2005,11(14):2117-2123. 被引量:69
  • 2何成强,李丛丛,吴艳红,安利国,李云龙.PPARδ启动子克隆及活性分析[J].生物化学与生物物理进展,2007,34(4):412-417. 被引量:3
  • 3马瑶,程海东.PPAR基因多态性的研究进展[J].中国优生与遗传杂志,2007,15(9):6-9. 被引量:3
  • 4Jamaluddin M, Wang S, Boldogh I, et al. TNF-alpha-induced NF-kappaB/RelA Ser (276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway [ J ]. Cell Signal, 2007,19 ( 7 ) : 1419-1433.
  • 5Wang Y, Mo X, Piper M G, et al. MoCSF induces monocyte survival by activating NF-kappaB p65 phosphorylation at Ser276 via protein kinase C [ J ]. PLoS One, 2011, 6 (12) : e28081.
  • 6Nihira K, Ando Y, Yamaguchi T, et al. Pim-1 controls NF- kappaB signalling by stabilizing RelA/p65 [ J ]. Cell Death Differ, 2010,17(4) :689-698.
  • 7Mattioli I, Geng H, Sebald A, et al. Inducible phosphorylation of NF-kappa B p65 at serine 468 hy T cell eostimulation is mediated by IKK epsilon [ J ]. J Biol Chem, 2006,281 (10) : 6175-6183.
  • 8Adli M, Baldwin A S. IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser536 p65/RelA phosphorylation [ J ]. J Biol Chem, 2006,281( 37 ) : 26976-26984.
  • 9Hoberg J E, Popko A E, Ramsey C S, et al. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300[J]. Mol Cell Biol, 2006,26(2) :457-471.
  • 10Msaki A, Sanchez A M, Koh L F, et al. The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration [ J]. Mol Biol Cell, 2011 , 22 ( 17 ) :3032-3040.

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部